Under construction – not a live service
Sign in
Not yet taking people in ChinaNo phase

Screening people at high risk for chronic obstructive pulmonary disease

A questionnaire survey looks for risk factors in adults at high risk of COPD.

Plain-language title generated from the registry record
Registry title: Screening for High-risk Chronic Obstructive Pulmonary Disease

Key facts

Where
Zhengzhou, ChinaSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

Source: NCT06350305, who can take part

Where in China

  • The First Affiliated Hospital of Henan University of Chinese MedicineZhengzhou, ChinaNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Henan University of Traditional Chinese Medicine
Trial code
NCT06350305
Record updated
11 April 2024
Original description
This study is a multicenter cross-sectional study design aimed at screening risk factors for the combination of disease and syndrome in high-risk individuals with chronic obstructive pulmonary disease (COPD).Read full original descriptionShow less

Screening Study at High-risk Chronic Obstructive Pulmonary Disease

This study is a multicenter cross-sectional study design aimed at screening risk factors for the combination of disease and syndrome in high-risk individuals with chronic obstructive pulmonary disease (COPD).

Inclusion: According to the Diagnosis and Treatment Guidelines for Chronic Obstructive Pulmonary Disease (Revised in 2021), a multi-stage cluster random sampling method was used to select individuals from representative administrative villages with a history of chronic cough or sputum production, breathing difficulties, recurrent lower respiratory tract infections, and/or exposure to potential risk factors for chronic obstructive pulmonary disease; The investigators agreed to participate in this clinical study by voluntarily signing an informed consent form.

Exclusion: Patients who are delirious, have impaired consciousness, dementia, various psychiatric disorders, etc., and cannot be accurately informed of their basic physical condition; Patients who, in the opinion of the investigator, are not suitable for participation in this study.

ClinicalTrials.gov NCT06350305